Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Ellis

Showing results (141-150 of 285) with videos related to

Pageof 29
Sort By:
Oncotarget|September 20, 2014
Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCCKaihua Zhang, Lamont Jones, Sora Lim, et al.
Journal of the American College of Surgeons|May 30, 2009
Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trialJohn A Olson, G Thomas Budd, Lisa A Carey, et al.
Breast Cancer Research : BCR|August 27, 2013
Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC CohortJudith-Anne W Chapman, Torsten O Nielsen, Matthew J Ellis, et al.
Cancer Discovery|December 11, 2012
Activating HER2 mutations in HER2 gene amplification negative breast cancerRon Bose, Shyam M Kavuri, Adam C Searleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal womenAnita K Dunbier, Helen Anderson, Zara Ghazoui, et al.
Transplantation Direct|March 20, 2023
MyKidneyCoach, Patient Activation, and Clinical Outcomes in Diverse Kidney Transplant Recipients: A Randomized Control Pilot TrialMcLean D Pollock, Nicolas Stauffer, Hui-Jie Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2019
miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL StudyLoki Natarajan, Minya Pu, Sherri R Davies, et al.
The Journal of Molecular Diagnostics : JMD|December 21, 2016
An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast TumorsJingqin Luo, Shuzhen Liu, Samuel Leung, et al.
Breast Cancer Research and Treatment|September 23, 2019
Research-based PAM50 signature and long-term breast cancer survivalMinya Pu, Karen Messer, Sherri R Davies, et al.
Breast Cancer Research and Treatment|January 17, 2012
Phase II trial of temsirolimus in patients with metastatic breast cancerGini F Fleming, Cynthia X Ma, Dezheng Huo, et al.
Pageof 29

Showing results (141-150 of 285) with videos related to

Sort By:
Pageof 29
Oncotarget|September 20, 2014
Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCCKaihua Zhang, Lamont Jones, Sora Lim, et al.
Journal of the American College of Surgeons|May 30, 2009
Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trialJohn A Olson, G Thomas Budd, Lisa A Carey, et al.
Breast Cancer Research : BCR|August 27, 2013
Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC CohortJudith-Anne W Chapman, Torsten O Nielsen, Matthew J Ellis, et al.
Cancer Discovery|December 11, 2012
Activating HER2 mutations in HER2 gene amplification negative breast cancerRon Bose, Shyam M Kavuri, Adam C Searleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal womenAnita K Dunbier, Helen Anderson, Zara Ghazoui, et al.
Transplantation Direct|March 20, 2023
MyKidneyCoach, Patient Activation, and Clinical Outcomes in Diverse Kidney Transplant Recipients: A Randomized Control Pilot TrialMcLean D Pollock, Nicolas Stauffer, Hui-Jie Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2019
miRNAs and Long-term Breast Cancer Survival: Evidence from the WHEL StudyLoki Natarajan, Minya Pu, Sherri R Davies, et al.
The Journal of Molecular Diagnostics : JMD|December 21, 2016
An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast TumorsJingqin Luo, Shuzhen Liu, Samuel Leung, et al.
Breast Cancer Research and Treatment|September 23, 2019
Research-based PAM50 signature and long-term breast cancer survivalMinya Pu, Karen Messer, Sherri R Davies, et al.
Breast Cancer Research and Treatment|January 17, 2012
Phase II trial of temsirolimus in patients with metastatic breast cancerGini F Fleming, Cynthia X Ma, Dezheng Huo, et al.
Pageof 29